Anbogen Therapeutics, Inc

Calculating rank

USPTO Granted Patents = 2

Forward Citations = 0

Loading Chart...

3 inventors (with patents filed for the assignee):

Tsu-An Hsu (2 out of 17 patents)

Sue-Ming Chang (2 out of 2 patents)

Hsing-Pang Hsieh (1 out of 20 patents)

2 patents: Sort by Forward Citations

1. 12252469 - Crystalline forms of (E)-N-hydroxy-3-(1-(phenylsulfonyl)indolin-5-yl)acrylamide (2025-03-18),

2. 12240858 - Crystalline forms of (S, E)-4-(dimethylamino)-N-(3-(4-(2-hydroxy-1-phenylethylamino)-6-phenylfuro[2,3-d]pyrimidin-5-yl)phenyl)but-2- enamide free base (2025-03-04),

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

2 Patents

#1,501 in Taipei

#4,259 in Taiwan

Taipei, Taiwan

Anbogen Therapeutics, Inc

Forward Citations = 0

3 inventors:

Tsu-An Hsu (2 out of 17 patents)

Sue-Ming Chang (2 out of 2 patents)

Hsing-Pang Hsieh (1 out of 20 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Anbogen Therapeutics, Inc. Retrieved from https://idiyas.com/company/anbogen-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]